NCT04736641

Brief Summary

The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 3, 2021

Completed
26 days until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

May 4, 2021

Status Verified

May 1, 2021

Enrollment Period

1.5 years

First QC Date

January 30, 2021

Last Update Submit

May 1, 2021

Conditions

Keywords

Hip diseaseReliabilityValidityCross-cultural adaptation

Outcome Measures

Primary Outcomes (1)

  • Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ)

    Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire is designed to evaluate quality of life related to hip disorders.

    15 minutes

Study Arms (1)

Patients group

Individuals with hip disease and chronic pain on hip

Other: Survey study

Interventions

Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) will be applied

Patients group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will consist of individuals with hip disease and chronic pain on hip.

You may qualify if:

  • Any diagnosed hip disease,
  • Chronic hip pain,
  • History of pain when lying or during weight-bearing activities, aggravated by activity for more than 3 months.

You may not qualify if:

  • Lumbar spine nerve root findings,
  • History of lumbar spine or hip surgery,
  • Corticosteroid injection to hip in the past 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Halime ARIKAN

Ankara, None Selected, 06490, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Longitudinal Studies

Intervention Hierarchy (Ancestors)

Cohort StudiesEpidemiologic StudiesEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Halime ARIKAN, MSc.

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

January 30, 2021

First Posted

February 3, 2021

Study Start

March 1, 2021

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

May 4, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will share
Shared Documents
CSR

Locations